Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment
Clinical trial NCT05552859 · TERMINATED
Trial details
- NCT number
- NCT05552859
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-05
- Primary completion
- 2023-07-28
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.